GHK-Cu Guide

GHK-Cu is a copper-binding tripeptide complex built from the amino acid sequence glycyl-L-histidyl-L-lysine and copper. FDA substance records list prezatide copper with synonyms that include Copper Tripeptide-1, GHK copper, and GHK complex with copper. [1]

Most public interest in GHK-Cu comes from skin-care, hair-care, and tissue-repair marketing. The strongest mainstream use context is topical cosmetic formulation, where Copper Tripeptide-1 appears as a skin-conditioning ingredient. That is different from proving that GHK-Cu treats wounds, reverses aging, regrows hair, or is safe to inject. [2][5][6]

A good evidence reading is conservative: GHK-Cu has plausible skin-biology mechanisms and some small or formulation-specific cosmetic studies, but many online claims go beyond the quality and scope of the human data. [6][7][8]

GHK is described in the literature as a naturally occurring tripeptide found in human fluids such as plasma, saliva, and urine. It has affinity for copper and is often discussed as a copper-complexed signal peptide in skin-remodeling research. [6]

The proposed biology is not a single receptor switch. Reviews describe effects on extracellular-matrix turnover, collagen and glycosaminoglycan signaling, metalloproteinase balance, fibroblast activity, immune-cell context, and antioxidant or inflammatory gene-expression pathways. These mechanisms are mostly drawn from cell, animal, ex vivo, and small clinical/cosmetic datasets. [6][8]

Copper matters because copper-dependent enzymes participate in connective-tissue biology and redox processes. That does not mean that adding more copper peptide is automatically better; biological plausibility is not the same as clinical proof, and copper exposure has to be considered in the context of the full formulation and route. [5][6]

The cosmetic safety review literature treats Copper Tripeptide-1 and related peptides as skin-conditioning agents used at very low concentrations in cosmetics. The Cosmetic Ingredient Review panel concluded that the reviewed ingredients were safe in cosmetics under the practices and concentrations described in that assessment. [5]

A review of GHK skin-regeneration biology summarizes older facial and cosmetic studies reporting improvements in appearance-related endpoints such as skin laxity, clarity, density, and fine lines. Those findings are useful for background, but they should be weighed against the age of the studies, product-specific formulations, and the gap between cosmetic outcomes and medical claims. [6]

A small randomized study after CO2 laser resurfacing found no statistically significant objective improvement in erythema resolution, wrinkles, or overall skin quality from adding GHK-Cu skin-care products, although a patient questionnaire showed one subjective overall skin-quality signal. This is a reminder that not all controlled human data are strongly positive. [7]

Human skin penetration has been evaluated ex vivo. One study reported that copper applied as a GHK-Cu related compound could penetrate and be retained in skin layers under the study conditions. Penetration data help explain why topical research is plausible, but they do not establish a disease treatment or an injectable use case. [8]

Skin appearance claims have the most relevant support, but the honest wording is still limited: GHK-Cu may support cosmetic appearance endpoints in some topical formulations. It should not be framed as a guaranteed collagen builder, scar remover, or anti-aging drug. [5][6][7]

Wound-healing and tissue-repair claims are biologically plausible and studied in preclinical or controlled research contexts, but they should not be translated into self-treatment guidance. Open wounds, burns, surgical sites, ulcers, and infections require qualified medical care rather than peptide self-experimentation. [6][8]

Hair-growth claims are common online, but this draft treats them as lower-certainty unless supported by direct, high-quality human hair-loss trials for the exact product and population being discussed. Cosmetic scalp marketing should not be confused with approved alopecia treatment. [6]

Systemic anti-aging, injury recovery, joint repair, and injectable wellness claims are not supported by the same level of evidence as a regulated therapeutic indication. FDA has separately flagged compounded injectable GHK-Cu for potential immunogenicity risks from aggregation and peptide-related impurities, with limited human data for safety assessment. [3]

Topical cosmetic use and injectable use should be treated as different risk categories. A cosmetic ingredient safety conclusion at low topical-use concentrations does not establish sterility, systemic safety, or safety for injection. [3][5]

FDA has listed GHK-Cu for injectable routes of administration among bulk drug substances that may present significant safety risks in compounding. FDA specifically noted potential immunogenicity risk related to aggregation and peptide-related impurities, along with limited human safety data. [3]

FDA also added GHK-Cu for non-injectable routes back to Category 1, meaning under evaluation, in its May 14, 2026 503A bulk drug substances update. Category 1 under evaluation should not be read as approval, endorsement, or proof of clinical benefit. [4]

For topical cosmetics, possible real-world issues include irritation, allergy, sensitization to other ingredients in the formula, use around compromised skin, contamination from poor manufacturing, and confusion between cosmetic, research, and drug-like products. [2][5]

There is no single public FDA-approved GHK-Cu drug label that sets consumer storage, reconstitution, or administration instructions. For cosmetics, follow the product label, expiration dating, and manufacturer safety information for that finished cosmetic product. [2][3][4]

Research-material handling instructions are not medical-use instructions. Labels such as research use only, lyophilized powder, sterile, cosmetic grade, or high purity do not by themselves prove that a product is appropriate for human use. [3][4]

This profile does not provide reconstitution, injection, concentration, cycling, stack, or shelf-life protocols. Those details can easily become dosing guidance and are outside the educational purpose of this page.